![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]()
London - May 20, 2002 Scientists from Imperial College London have successfully directed mouse stem cells to turn into the type of cells needed for gas exchange in lungs, bringing the prospect of being able to regenerate damaged lung tissue, and even the creation of artificially grown lungs one step closer. Dr Anne Bishop, from Imperial College Tissue Engineering and Regenerative Medicine Centre at Chelsea and Westminster Hospital, comments: "This research will make it possible eventually to repair lungs that have been damaged by disease, by implanting fully functioning lung cells to repopulate damaged areas. Also, unlike transplantation from a donor, the cells can be developed in such a way that the body will not reject them". The research, the first of its kind in the world, involved taking mouse stem cells, and then placing them in a specialized growth system, which encouraged them to change into the cells that line the part of the lung where oxygen is absorbed and carbon dioxide excreted. Professor Julia Polak, Director of the Centre, adds: "This is the first time research of this nature has been carried out, and it has provided us with a crucial building block towards being able to construct lung tissue. It could eventually mean the end of extensive transplant waiting lists for critically ill patients." The researchers at Imperial College Tissue Engineering and Regenerative Medicine Centre at Chelsea and Westminster Hospital now plan to use their findings to begin development of a living construct, using specially designed bioactive foams and scaffolds. The bioactive scaffolds will provide a frame on which the cells can grow, and then be transplanted. Lung disease continues to be a major cause of death in the UK and a large-scale clinical problem. Life-threatening lung diseases include emphysema, chronic obstructive pulmonary disease, cystic fibrosis, and pulmonary hypertension. Presently the only sure way of addressing end-stage lung disease is transplantation from another person. Transplantation has revolutionised the approach to end stage pulmonary diseases and it has allowed patients to regain 10 to 20 years of active life. However there are two major drawbacks to 'conventional' transplantation: the chronic shortage of donor organs and the risk of rejection of the organs after transplantation. This new discovery could address both these issues, say the scientists. Stem cells have great therapeutic potential. Diseases that are potential candidates for stem cell therapy include lung disease, diabetes, Parkinson's disease, osteoporosis, Alzheimer's disease, and heart disease. Derivation of type II alveolar epithelial cells from murine embryonic stem cells � Tissue Engineering Journal, August 2002 (Vol, 8, No. 4). Community Email This Article Comment On This Article Related Links The Tissue Engineering and Regenerative Centre SpaceDaily Search SpaceDaily Subscribe To SpaceDaily Express Dirt, rocks and all the stuff we stand on firmly
![]() ![]() Environmental damage threatens human health and may have contributed to the spread of new diseases like bird flu and SARS, the World Health Organization said in a report Friday. |
![]() |
|
The content herein, unless otherwise known to be public domain, are Copyright 1995-2006 - SpaceDaily.AFP and UPI Wire Stories are copyright Agence France-Presse and United Press International. ESA PortalReports are copyright European Space Agency. All NASA sourced material is public domain. Additionalcopyrights may apply in whole or part to other bona fide parties. Advertising does not imply endorsement,agreement or approval of any opinions, statements or information provided by SpaceDaily on any Web page published or hosted by SpaceDaily. Privacy Statement |